VP RAQA
Oxford Endovascular Ltd
Rebecca has been in the medical device industry for nearly 30 years. She started her career at the MHRA during the implementation of the Medical Devices directives in the technical areas of critical care and implantable devices.
In 1997 Rebecca joined industry in the field of Regulatory, Quality and Clinical worked for 15 years in global medical devices companies in the areas of cardiology, orthopaedics and critical care and had success developing Regulatory Strategies to support introduction of new technologies in these sectors as well as developing innovative solutions to address changing Regulatory requirements to ensure ongoing compliance for legacy products.
For the past decade Rebecca has primarily focussed on start-ups in Europe and the UK in the fields of cardiology, neurostimulation and neuromuscular devices helping them to navigate the every changing Regulatory landscape with a strong emphasis on collaboration with global Regulators to support an efficient pathway from concept to commercialisation.
Disclosure information not submitted.
EMA Scientific Advice for High-Risk Devices – What We Know So Far
Tuesday, May 7, 2024
16:45 – 17:45 CEST